Saffold virus type 3 (SAFV-3) persists in HeLa cells

Toshiki Himeda1, Takushi Hosomi, Takako Okuwa

  • 1Department of Microbiology, Kanazawa Medical University School of Medicine, Ishikawa, Japan.

Plos One
|January 12, 2013
PubMed

Insights

Saffold virus (SAFV) can persistently infect human cells, unlike its related virus TMEV. This persistent infection in HeLa-R cells is independent of the host

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Saffold virus (SAFV), a human cardiovirus, was identified in 2007.
  • Epidemiological studies have not clarified the link between SAFV and human diseases.
  • SAFV genotype 3 has been found in cerebrospinal fluid of patients with aseptic meningitis, similar to TMEV which causes a multiple sclerosis-like syndrome in mice.

Purpose of the Study:

  • To investigate the in vitro persistent infection of Saffold virus (SAFV).
  • To clarify the pathogenicity mechanisms of SAFV.
  • To compare SAFV infection patterns with Theiler's murine encephalomyelitis virus (TMEV).

Main Methods:

  • Utilized two distinct HeLa cell phenotypes (HeLa-N and HeLa-R) to study SAFV-3 infection.
  • Assessed viral growth and persistence in different cell types.
  • Investigated the role of type I interferon response in SAFV persistence.

Main Results:

  • HeLa-N cells supported lytic SAFV-3 infection and efficient viral growth.
  • HeLa-R cells exhibited persistent SAFV-3 infection.
  • SAFV persistence in HeLa-R cells was independent of the host's type I interferon response, contrasting with TMEV persistence.

Conclusions:

  • SAFV can establish persistent infections in human cells (HeLa-R).
  • SAFV persistence mechanisms differ from TMEV, notably being independent of type I IFN response.
  • Receptor expression on host cells may influence SAFV persistence, warranting further research into SAFV pathogenicity.

Related Concept Videos